Llwytho...

Myeloid Angiogenic Cells Act as Alternative M2 Macrophages and Modulate Angiogenesis through Interleukin-8

Endothelial progenitor cells (EPCs) promote angiogenesis, and clinical trials have shown such cell therapy to be feasible for treating ischemic disease. However, clinical outcomes have been contradictory owing to the diverse range of EPC types used. We recently characterized two EPC subtypes, and id...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Medina, Reinhold J, O’Neill, Christina L, O’Doherty, T Michelle, Knott, Henry, Guduric-Fuchs, Jasenka, Gardiner, Tom A, Stitt, Alan W
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	ScholarOne 2011
Pynciau:	Articles
Mynediad Ar-lein:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3188859/ https://ncbi.nlm.nih.gov/pubmed/21670847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00129
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Myeloid Angiogenic Cells Act as Alternative M2 Macrophages and Modulate Angiogenesis through Interleukin-8

Eitemau Tebyg